Skip to content

Clinical trials

Heart Valve Diseases trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Valve Diseases Phase: Not applicable Country / region: China Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20103
20111
20121
20131
20172
20192
20202
20212
20224
20231
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status9
Not yet recruiting5
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Anzhen Hospital3
Nanjing Medical University3
Sun Yat-sen University3
China National Center for Cardiovascular Diseases2
Chinese Academy of Medical Sciences, Fuwai Hospital2
Guangdong Provincial People's Hospital2
Qianfoshan Hospital2
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Hepatopancreatobiliary Surgery Institute of Gansu Province1
ICE Intelligent Healthcare Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Valve Diseases26
Cardiovascular Diseases4
Coronary Artery Disease4
Heart Defects, Congenital4
Aortic Dissection3
Arrhythmias, Cardiac3
Aortic Valve Stenosis2
Atrial Fibrillation2
Rheumatic Heart Disease2
Aneurysm1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.